deferasirox

Generic: deferasirox

Labeler: xiromed, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name deferasirox
Generic Name deferasirox
Labeler xiromed, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

deferasirox 180 mg/1

Manufacturer
Xiromed, LLC

Identifiers & Regulatory

Product NDC 70700-270
Product ID 70700-270_bb29f5e5-53df-4432-b6d1-854fa1e54d83
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212995
Listing Expiration 2026-12-31
Marketing Start 2020-06-15

Pharmacologic Class

Established (EPC)
iron chelator [epc]
Mechanism of Action
iron chelating activity [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 1a2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70700270
Hyphenated Format 70700-270

Supplemental Identifiers

RxCUI
1607784 1607792 1607796
UPC
0370700271308 0370700269305 0370700270301
UNII
V8G4MOF2V9
NUI
N0000000144 N0000175522 N0000185506 N0000187062 N0000182138

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deferasirox (source: ndc)
Generic Name deferasirox (source: ndc)
Application Number ANDA212995 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE, PLASTIC (70700-270-30)
source: ndc

Packages (1)

70700-270-30 30 TABLET in 1 BOTTLE, PLASTIC (70700-270-30)

Ingredients (1)

deferasirox (180 mg/1)

Linked Drug Pages (1)

Deferasirox ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "bb29f5e5-53df-4432-b6d1-854fa1e54d83", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "upc": ["0370700271308", "0370700269305", "0370700270301"], "unii": ["V8G4MOF2V9"], "rxcui": ["1607784", "1607792", "1607796"], "spl_set_id": ["4c36bb5a-2552-46c1-8500-4ae783cffef1"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Xiromed, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70700-270-30)", "package_ndc": "70700-270-30", "marketing_start_date": "20200615"}], "brand_name": "Deferasirox", "product_id": "70700-270_bb29f5e5-53df-4432-b6d1-854fa1e54d83", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "70700-270", "generic_name": "Deferasirox", "labeler_name": "Xiromed, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasirox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "180 mg/1"}], "application_number": "ANDA212995", "marketing_category": "ANDA", "marketing_start_date": "20200615", "listing_expiration_date": "20261231"}